sulfamethoxazole has been researched along with Thrombocytopathy in 2 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Claas, FH | 1 |
| van der Meer, JW | 1 |
| Langerak, J | 1 |
| Dry, J | 1 |
| Leynadier, F | 1 |
| Herman, D | 1 |
| Pradalier, A | 1 |
2 other studies available for sulfamethoxazole and Thrombocytopathy
| Article | Year |
|---|---|
Immunological effect of co-trimoxazole on platelets.
Topics: Adult; Antibodies; Blood Platelet Disorders; Blood Platelets; Cell Survival; Drug Combinations; Fema | 1979 |
[Letter: Sulfamethoxazole-trimethoprim combination (cotrimoxazole). Unusual immuno-allergic reaction].
Topics: Blood Platelet Disorders; Drug Combinations; Drug Hypersensitivity; Drug Tolerance; Female; Humans; | 1975 |